Nikolaj Klose - Bilendi Head Management
| ALBLD Stock | EUR 13.20 0.15 1.15% |
Insider
Nikolaj Klose is Head Management of Bilendi
| Phone | 33 1 44 88 60 30 |
| Web | https://www.bilendi.fr |
Bilendi Management Efficiency
The company has return on total asset (ROA) of 0.0725 % which means that it generated a profit of $0.0725 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1895 %, meaning that it generated $0.1895 on every $100 dollars invested by stockholders. Bilendi's management efficiency ratios could be used to measure how well Bilendi manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Didier Hornet | Vallourec | 59 | |
| Jeanne Castaing | Etablissements Maurel et | N/A | |
| DVM MBA | Innate Pharma | 58 | |
| Philippe Carlier | Vallourec | N/A | |
| Philippe Guillemot | Vallourec | 64 | |
| Alain Torre | Etablissements Maurel et | N/A | |
| Olivier Langavant | Etablissements Maurel et | 66 | |
| Pascal Caisey | Genfit | 55 | |
| PaulAndre Canel | Etablissements Maurel et | 69 | |
| Marc Bonneville | Innate Pharma | 63 | |
| Stefanie Magner | Genfit | 42 | |
| Matthieu Lefrancq | Etablissements Maurel et | N/A | |
| Pascal Braquehais | Vallourec | 57 | |
| Jean Fourni | Innate Pharma | N/A | |
| Franois Romagn | Innate Pharma | 59 | |
| JeanPhilippe Hagry | Etablissements Maurel et | N/A | |
| Jerome Friboulet | Vallourec | N/A | |
| Thomas Baetz | Genfit | 49 | |
| Sascha Bibert | Vallourec | 47 | |
| Frederic MBA | Innate Pharma | 48 | |
| Patrick Deygas | Etablissements Maurel et | N/A | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0725 |
Bilendi Leadership Team
Elected by the shareholders, the Bilendi's board of directors comprises two types of representatives: Bilendi inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bilendi. The board's role is to monitor Bilendi's management team and ensure that shareholders' interests are well served. Bilendi's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bilendi's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marc Foisil, Adm CFO | ||
| Herv Piedvache, Chief Officer | ||
| Maria Pedersen, Head Nordics | ||
| Marc Bidou, Chairman of the Board, CEO | ||
| Stephanie Incera, Chief Officer | ||
| Nikolaj Klose, Head Management | ||
| Steen Agerskov, Chief Nordics | ||
| Daniel Cunill, Head ResearchUK | ||
| Hicham Amadi, GM Pres | ||
| Robin Spicer, Operations DACH |
Bilendi Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bilendi a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0725 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 88.77 M | |||
| Shares Outstanding | 4.49 M | |||
| Shares Owned By Institutions | 54.38 % | |||
| Price To Earning | 22.67 X | |||
| Price To Book | 2.79 X | |||
| Price To Sales | 1.65 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bilendi Stock Analysis
When running Bilendi's price analysis, check to measure Bilendi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bilendi is operating at the current time. Most of Bilendi's value examination focuses on studying past and present price action to predict the probability of Bilendi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bilendi's price. Additionally, you may evaluate how the addition of Bilendi to your portfolios can decrease your overall portfolio volatility.